FENC
FENNEC PHARMACEUTICALS INC.
Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
75
Buys
3
Sells
47
Largest Trade
N/A
Insiders
6
Institutional Funds
72
Inst. Value
$1M+
Activist Filings
12
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Raykov Rosty | Director | EXERCISE | $15K–$50K | 16K | $2.45 | Mar 3, 2026 |
| Raykov Rosty | Director | GRANT | N/A | 5K | — | Mar 3, 2026 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $8.36 | Mar 3, 2026 |
| Raykov Rosty | Director | EXERCISE | $15K–$50K | 16K | $2.45 | Feb 2, 2026 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $7.76 | Feb 2, 2026 |
| Raykov Rosty | Director | EXERCISE | $15K–$50K | 16K | $2.45 | Jan 5, 2026 |
| Raykov Rosty | Director | GRANT | N/A | 5K | — | Jan 5, 2026 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $7.60 | Jan 5, 2026 |
| Southpoint Capital Advisors LP | 10% Owner | SELL | $1M+ | 1.0M | $7.50 | Dec 29, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $7.54 | Dec 5, 2025 |
| Southpoint Capital Advisors LP | 10% Owner | SELL | $100K–$500K | 19K | $8.79 | Nov 20, 2025 |
| Southpoint Capital Advisors LP | 10% Owner | SELL | $1M+ | 246K | $8.27 | Nov 18, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $8.10 | Nov 6, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $8.92 | Sep 4, 2025 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 2K | $2.35 | Jul 7, 2025 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 1K | $8.71 | Jul 7, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $8.61 | Jul 7, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $7.78 | Jun 6, 2025 |
| Hackman Jeffrey S. | CEO | BUY | $100K–$500K | 15K | $6.97 | May 19, 2025 |
| Raykov Rosty | Director | SELL | $100K–$500K | 17K | $6.78 | May 19, 2025 |
| Raykov Rosty | Director | GRANT | N/A | 33K | — | May 19, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $6.31 | May 5, 2025 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 2K | $2.30 | Apr 11, 2025 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 1K | $4.95 | Apr 11, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $5.25 | Apr 4, 2025 |
| Raykov Rosty | Director | SELL | $50K–$100K | 10K | $6.08 | Jan 7, 2025 |
| Raykov Rosty | Director | SELL | $1K–$15K | 2K | $6.13 | Dec 4, 2024 |
| Raykov Rosty | Director | GRANT | N/A | 2K | — | Dec 4, 2024 |
| RALLIS CHRIS A | Director | EXERCISE | $15K–$50K | 10K | $2.69 | Dec 3, 2024 |
| RALLIS CHRIS A | Director | SELL | $15K–$50K | 6K | $6.14 | Dec 3, 2024 |
| Raykov Rosty | Director | SELL | $1K–$15K | 2K | $4.31 | Nov 4, 2024 |
| Raykov Rosty | Director | GRANT | N/A | 2K | — | Nov 4, 2024 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 2K | $2.55 | Oct 10, 2024 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 1K | $4.53 | Oct 10, 2024 |
| Raykov Rosty | Director | SELL | $1K–$15K | 2K | $4.94 | Oct 1, 2024 |
| Raykov Rosty | Director | GRANT | N/A | 2K | — | Oct 1, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | GRANT | N/A | 2K | — | Aug 1, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $15K–$50K | 2K | $6.25 | Aug 1, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $1K–$15K | 2K | $6.13 | Jul 2, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | GRANT | N/A | 2K | — | Jul 2, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | GRANT | N/A | 2K | — | Jun 3, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $15K–$50K | 2K | $6.76 | Jun 3, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | GRANT | N/A | 2K | — | May 2, 2024 |
| Raykov Rosty | CHIEF EXECUTIVE OF… | SELL | $15K–$50K | 2K | $9.11 | May 2, 2024 |
| Haigh Adrian | CHIEF OPERATING OF… | SELL | $100K–$500K | 44K | $9.33 | Apr 22, 2024 |
| Haigh Adrian | CHIEF OPERATING OF… | EXERCISE | $100K–$500K | 44K | $2.31 | Apr 22, 2024 |
| Haigh Adrian | CHIEF OPERATING OF… | SELL | $500K+ | 89K | $6.04 | Apr 19, 2024 |
| Haigh Adrian | CHIEF OPERATING OF… | SELL | $500K+ | 89K | $6.30 | Apr 16, 2024 |
| RALLIS CHRIS A | Director | EXERCISE | $1K–$15K | 1K | $10.45 | Apr 15, 2024 |
| RALLIS CHRIS A | Director | SELL | $1K–$15K | 800 | $10.45 | Apr 15, 2024 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 72 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Southpoint Capital Advisors LP | 2.7M | $1M+ | SH |
| Rosalind Advisors, Inc. | 2.6M | $1M+ | SH |
| AWM Investment Company, Inc. | 712K | $1M+ | SH |
| AIGH Capital Management LLC | 422K | $1M+ | SH |
| STATE STREET CORP | 353K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 270K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 204K | $1M+ | SH |
| Lion Point Capital, LP | 112K | $500K+ | SH |
| Potomac Capital Management, Inc. | 95K | $500K+ | SH |
| GENDELL JEFFREY L | 66K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 57K | $100K–$500K | SH |
| Hartford Financial Management Inc. | 51K | $100K–$500K | SH |
| Stonepine Capital Management, LLC | 50K | $100K–$500K | SH |
| Hillsdale Investment Management Inc. | 44K | $100K–$500K | SH |
| BARCLAYS PLC | 37K | $100K–$500K | SH |
| VANGUARD GROUP INC | 36K | $100K–$500K | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 32K | $100K–$500K | SH |
| RHUMBLINE ADVISERS | 29K | $100K–$500K | SH |
| 1492 Capital Management LLC | 28K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 27K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 11, 2026
9.8%
2.7M shares
SC 13G/A · Jan 14, 2026
8.0%
2.7M shares
SC 13G · Nov 13, 2025
7.5%
2.1M shares
SC 13G/A · Feb 14, 2025
8.2%
2.3M shares
SC 13G/A · Feb 14, 2025
4.1%
1.1M shares
SC 13G/A · Nov 14, 2024
7.0%
1.9M shares
SC 13G/A · Nov 13, 2024
5.5%
1.5M shares
SC 13G · Jun 27, 2024
5.2%
1.4M shares
SC 13G · Feb 14, 2024
0.0%
1.4M shares
SC 13G/A · Feb 14, 2023
9.2%
2.4M shares
SC 13G/A · Feb 14, 2022
9.3%
2.4M shares
SC 13G/A · Feb 11, 2022
4.6%
1.2M shares